Search research articles
Contact Us
Filters
Showing results (291-300 of 401) with videos related to
Page
of 41
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 5, 2009
Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding
Sarah L Rea, John P Walsh, Lynley Ward, et al.
Scientific Reports
|
November 30, 2016
Calmodulin interacts with Rab3D and modulates osteoclastic bone resorption
Sipin Zhu, Shek Man Chim, Taksum Cheng, et al.
The Journal of Biological Chemistry
|
March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis
HaoTian Feng, Taksum Cheng, James H Steer, et al.
Frontiers in Pharmacology
|
December 12, 2019
Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
Jianbo He, Xiaojuan Li, Ziyi Wang, et al.
Frontiers in Pharmacology
|
February 15, 2021
Systemic Administration of Fibroblast Growth Factor 21 Improves the Recovery of Spinal Cord Injury (SCI) in Rats and Attenuates SCI-Induced Autophagy
Sipin Zhu, Yibo Ying, Lin Ye, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 6, 2023
Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways
Yiwu Qin, Dezhi Song, Shijie Liao, et al.
Frontiers in Pharmacology
|
January 5, 2024
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
Jianbo He, Kai Chen, Tiancheng Deng, et al.
International Journal of Molecular Medicine
|
November 8, 2024
Enocyanin promotes osteogenesis and bone regeneration by inhibiting MMP9
Wei Mao, Yinfeng Zheng, Wencong Zhang, et al.
Life Sciences
|
January 24, 2020
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption
Kun Tian, Yuangang Su, Jiaxin Ding, et al.
Journal of Cellular Physiology
|
August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
Estabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Page
of 41
Search research articles
Search
Showing results (291-300 of 401) with videos related to
Sort By:
Page
of 41
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 5, 2009
Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding
Sarah L Rea, John P Walsh, Lynley Ward, et al.
Scientific Reports
|
November 30, 2016
Calmodulin interacts with Rab3D and modulates osteoclastic bone resorption
Sipin Zhu, Shek Man Chim, Taksum Cheng, et al.
The Journal of Biological Chemistry
|
March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis
HaoTian Feng, Taksum Cheng, James H Steer, et al.
Frontiers in Pharmacology
|
December 12, 2019
Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
Jianbo He, Xiaojuan Li, Ziyi Wang, et al.
Frontiers in Pharmacology
|
February 15, 2021
Systemic Administration of Fibroblast Growth Factor 21 Improves the Recovery of Spinal Cord Injury (SCI) in Rats and Attenuates SCI-Induced Autophagy
Sipin Zhu, Yibo Ying, Lin Ye, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 6, 2023
Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways
Yiwu Qin, Dezhi Song, Shijie Liao, et al.
Frontiers in Pharmacology
|
January 5, 2024
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
Jianbo He, Kai Chen, Tiancheng Deng, et al.
International Journal of Molecular Medicine
|
November 8, 2024
Enocyanin promotes osteogenesis and bone regeneration by inhibiting MMP9
Wei Mao, Yinfeng Zheng, Wencong Zhang, et al.
Life Sciences
|
January 24, 2020
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption
Kun Tian, Yuangang Su, Jiaxin Ding, et al.
Journal of Cellular Physiology
|
August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
Estabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Page
of 41